288 related articles for article (PubMed ID: 26687550)
1. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.
Yerasi C; Baker NC; Jonnalagadda AK; Torguson R; Singh S; Vies J; Waksman R
J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
3. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
4. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
5. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
[TBL] [Abstract][Full Text] [Related]
6. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
7. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
[TBL] [Abstract][Full Text] [Related]
8. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
Briasoulis A; Bakris G
Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
[TBL] [Abstract][Full Text] [Related]
9. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
[TBL] [Abstract][Full Text] [Related]
10. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
11. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
[TBL] [Abstract][Full Text] [Related]
12. High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
Waksman R; Bakris GL; Steinvil A; Garcia-Garcia H; Brown AL; DiFilippo W; Scott T; Singh J; DeBruin V; Jones D; Jolivette D; Bhatt DL
Am Heart J; 2017 Oct; 192():76-84. PubMed ID: 28938966
[TBL] [Abstract][Full Text] [Related]
13. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
[TBL] [Abstract][Full Text] [Related]
14. Resistant Hypertension and Renal Nerve Denervation.
Denker MG; Cohen DL
Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients.
Hayek SS; Abdou MH; Demoss BD; Legaspi JM; Veledar E; Deka A; Krishnan SK; Wilmot KA; Patel AD; Kumar VR; Devireddy CM
Am J Hypertens; 2013 Dec; 26(12):1452-8. PubMed ID: 23934709
[TBL] [Abstract][Full Text] [Related]
17. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
18. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
[TBL] [Abstract][Full Text] [Related]
19. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Randomized Controlled Trials Comparing Renal Sympathetic Denervation Versus Sham Procedure for the Management of Uncontrolled Hypertension.
Maqsood MH; Rubab K; Anwar F; Afzal Khan MT; Maqsood MA; Farooq M; Tabaza L; Rangaswami J; Virk HUH
J Cardiovasc Pharmacol; 2021 Feb; 77(2):153-158. PubMed ID: 33235031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]